Читать книгу - "Энергия мозга. Теория развития всех психических заболеваний, объясняющая их общую причину - Кристофер М. Палмер"

“Impairment of Central and Peripheral Myelin in Mitochondrial Diseases.” Mult Scler 2(6) (1997): 267–278. doi: 10.1177/135245859700200602; E. M. R. Lake, E. A. Steffler, C. D. Rowley, et al. “Altered Intracortical Myelin Staining in the Dorsolateral Prefrontal Cortex in Severe Mental Illness.” Eur Arch Psychiatry Clin Neurosci 267 (2017): 369–376. doi: 10.1007/s00406-0160730-5; J. Rice and C. Gu. “Function and Mechanism of Myelin Regulation in Alcohol Abuse and Alcoholism.” Bioessays 41(7) (2019): e1800255. doi: 10.1002/bies.201800255. Epub May 16, 2019; Gerhard S. Drenthen, Walter H. Backes, Albert P. Aldenkamp, R. Jeroen Vermeulen, Sylvia Klinkenberg, and Jacobus F. A. Jansen. “On the Merits of Non-Invasive Myelin Imaging in Epilepsy, a Literature Review.” J Neurosci Methods 338 (2020): 108687. doi: 10.1016/j.jneumeth.2020.108687; E. Papuć and K. Rejdak. “The Role of Myelin Damage in Alzheimer’s Disease Pathology.” Arch Med Sci 16(2) (2018): 345–351. doi: 10.5114/ aoms.2018.76863; G. Cermenati, F. Abbiati, S. Cermenati, et al. “Diabetes-Induced Myelin Abnormalities Are Associated with an Altered Lipid Pattern: Protective Effects of LXR Activation.” J Lipid Res 53(2) (2012): 300–310. doi: 10.1194/jlr.M021188; M. Bouhrara, N. Khattar, P. Elango, et al. “Evidence of Association Between Obesity and Lower Cerebral Myelin Content in Cognitively Unimpaired Adults.” Int J Obes (Lond) 45(4) (2021): 850–859. doi: 10.1038/s41366-021-00749-x.

14. A. Ebneth, R. Godemann, K. Stamer, S. Illenberger, B. Trinczek, and E. Mandelkow. “Overexpression of Tau Protein Inhibits Kinesin-Dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer’s Disease.” J Cell Biol 143(3) (1998): 777–794. doi: 10.1083/jcb.143.3.777.

15. A. Cheng, J. Wang, N. Ghena, Q. Zhao, I. Perone, T. M. King, R. L. Veech, M. Gorospe, R. Wan, and M. P. Mattson. “SIRT3 Haploinsufficiency Aggravates Loss of GABAergic Interneurons and Neuronal Network Hyperexcitability in an Alzheimer’s Disease Model.” J Neurosci 40(3) (2020): 694–709. doi: 10.1523/ JNEUROSCI.1446-19.2019.

16. J. Mertens, et al. “Differential Responses to Lithium in Hyperexcitable Neurons from Patients with Bipolar Disorder.” Nature 527(7576) (2015): 95–99. doi: 10.1038/nature15526.

17. J. A. Rosenkranz, E. R. Venheim, and M. Padival. “Chronic Stress Causes Amygdala Hyperexcitability in Rodents.” Biol Psychiatry 67(12) (2010): 1128–1136. doi: 10.1016/j.biopsych.2010.02.008.

18. Marco Morsch, Rowan Radford, Albert Lee, Emily Don, Andrew Badrock, Thomas Hall, Nicholas Cole, and Roger Chung. “In Vivo Characterization of Microglial Engulfment of Dying Neurons in the Zebrafish Spinal Cord.” Front Cell Neurosci 9 (2015): 321. doi: 10.3389/fncel.2015.00321.

19. D. Alnæs, T. Kaufmann, D. van der Meer, et al. “Brain Heterogeneity in Schizophrenia and Its Association with Polygenic Risk.” JAMA Psychiatry 76(7) (published online April 10, 2019): 739–748. doi: 10.1001/ jamapsychiatry.2019.0257.

20. J. Allen, R. Romay-Tallon, K. J. Brymer, H. J. Caruncho, and L. E. Kalynchuk. “Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression.” Front Neurosci 12 (June 6, 2018): 386. doi: 10.3389/fnins.2018.00386.

21. D. Ben-Shachar and R. Karry. “Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies Between Schizophrenia, Bipolar Disorder and Major Depression.” PLoS One 3(11) (2008): e3676. doi: 10.1371/journal.pone.0003676.

22. J. Pu, Y. Liu, H. Zhang, et al. “An Integrated Meta-Analysis of Peripheral Blood Metabolites and Biological Functions in Major Depressive Disorder.” Mol Psychiatry 26 (2020): 4265–4276. doi: 10.1038/ s41380-020-0645-4.

23. C. Nasca, B. Bigio, F. S. Lee, et al. “Acetyl-L–Carnitine Deficiency in Patients with Major Depressive Disorder.” Proc Natl Acad Sci USA 115(34) (2018): 8627–8632. doi: 10.1073/pnas.1801609115.

24. Ait Tayeb, Abd El Kader, Romain Colle, Khalil El-Asmar, Kenneth Chappell, Cécile Acquaviva-Bourdain, Denis J. David, Séverine Trabado, et al. “Plasma Acetyl-L–Carnitine and L–Carnitine in Major Depressive Episodes: A Case – Control Study Before and After Treatment.” Psychol Med (2021): 1–10. doi: 10.1017/ S003329172100413X.

25. E. Gebara, O. Zanoletti, S. Ghosal, J. Grosse, B. L. Schneider, G. Knott, S. Astori, and C. Sandi. “Mitofusin-2 in the Nucleus Accumbens Regulates Anxiety and Depression-like Behaviors Through Mitochondrial and Neuronal Actions.” Biol Psychiatry 89(11) (2021): 1033–1044. doi: 10.1016/j.biopsych.2020.12.003.

26. M. D. Altschule, D. H. Henneman, P. Holliday, and R. M. Goncz. “Carbohydrate Metabolism in Brain Disease. VI. Lactate Metabolism After Infusion of Sodium d-Lactate in Manic-Depressive and Schizophrenic Psychoses.” AMA Arch Intern Med 98 (1956): 35–38. doi: 10.1001/archinte.1956.00250250041006.

27. Gerwyn Morris, Ken Walder, Sean L. McGee, Olivia M. Dean, Susannah J. Tye, Michael Maes, and Michael Berk. “A Model of the Mitochondrial Basis of Bipolar Disorder.” Neurosci Biobehav Rev 74 (2017): 1–20. doi: 10.1016/j.neubiorev.2017.01.014.

28. Anna Giménez-Palomo, Seetal Dodd, Gerard Anmella, Andre F. Carvalho, Giselli Scaini, Joao Quevedo, Isabella Pacchiarotti, Eduard Vieta, and Michael Berk. “The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.” Front Psychiatry 12 (2021): 977. doi: 10.3389/ fpsyt.2021.546801.

29. D. Wang, Z. Li, W. Liu, et al. “Differential Mitochondrial DNA Copy Number in Three Mood States of Bipolar Disorder.” BMC Psychiatry 18 (2018): 149. doi: 10.1186/s12888-018-1717-8.

30. G. Preston, F. Kirdar, and T. Kozicz. “The Role of Suboptimal Mitochondrial Function in Vulnerability to Post-traumatic Stress Disorder.” J Inherit Metab Dis 41(4) (2018): 585–596. doi: 10.1007/ s10545-018-0168-1.

31. S. Ali, M. Patel, S. Jabeen, R. K. Bailey, T. Patel, M. Shahid, W. J. Riley, and A. Arain. “Insight into Delirium.” Innov Clin Neurosci 8(10) (2011): 25–34. PMID: 22132368.

32. A. J. Slooter, D. Van, R. R. Leur, and I. J. Zaal. “Delirium in Critically Ill Patients.” Handb Clin Neurol 141 (2017): 449–466. doi: 10.1016/B978-0-444-63599-0.00025-9.

33. G. L. Engel and J. Romano. “Delirium, a Syndrome of Cerebral Insufficiency.” J Chronic Dis. 9(3) (1959): 260–277. doi: 10.1016/0021-9681(59)90165-1.

34. J. E. Wilson, M. F. Mart, C. Cunningham, et al. “Delirium.” Nat Rev Dis Primers 6 (2020): 90. doi: 10.1038/ s41572-020-00223-4.

35. L. R. Haggstrom, J. A. Nelson, E. A. Wegner, and G. A. Caplan. “2-(18)F-fluoro-2-deoxyglucose Positron Emission Tomography in Delirium.” J. Cereb. Blood Flow Metab 37(11) (2017): 3556–3567. doi: 10.1177/0271678X17701764.

36. A. J. Slooter, D. Van, R. R. Leur, and I. J. Zaal. “Delirium in Critically Ill Patients.” Handb Clin Neurol 141 (2017): 449–466. doi: 10.1016/B978-0-444-63599-0.00025-9; T. E. Goldberg, C. Chen, Y. Wang, et al. “Association of Delirium with Long-Term Cognitive Decline: A Meta-analysis.” JAMA Neurol. Published online July 13,